7780 — Daiken Biomedical Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMid CapNeutral

Annual balance sheet for Daiken Biomedical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	244	287	1,140	5,262
Net Total Accounts Receivable
Net Total Receivables	53.5	71.5	94.2	144
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	524	733	1,511	5,863
Net Property, Plant And Equipment	—	0	3.28	19.3
Net Intangible Assets
Other Long Term Assets
Total Assets	530	745	1,538	5,913
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	241	448	230	447
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	303	498	231	470
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	227	247	1,307	5,443
Total Liabilities & Shareholders' Equity	530	745	1,538	5,913
Total Common Shares Outstanding